ATE309354T1 - Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen - Google Patents

Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen

Info

Publication number
ATE309354T1
ATE309354T1 AT00954207T AT00954207T ATE309354T1 AT E309354 T1 ATE309354 T1 AT E309354T1 AT 00954207 T AT00954207 T AT 00954207T AT 00954207 T AT00954207 T AT 00954207T AT E309354 T1 ATE309354 T1 AT E309354T1
Authority
AT
Austria
Prior art keywords
rbt1
replication protein
transcription factor
binding transcription
protein
Prior art date
Application number
AT00954207T
Other languages
English (en)
Inventor
Moulay A Alaoui-Jamali
John Myung-Jae Cho
Original Assignee
Ct For Translational Res In Ca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct For Translational Res In Ca filed Critical Ct For Translational Res In Ca
Application granted granted Critical
Publication of ATE309354T1 publication Critical patent/ATE309354T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00954207T 1999-08-19 2000-08-17 Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen ATE309354T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14947299P 1999-08-19 1999-08-19
PCT/CA2000/000948 WO2001014546A2 (en) 1999-08-19 2000-08-17 Replication protein a binding transcriptional factor (rbt1) and uses thereof

Publications (1)

Publication Number Publication Date
ATE309354T1 true ATE309354T1 (de) 2005-11-15

Family

ID=22530436

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954207T ATE309354T1 (de) 1999-08-19 2000-08-17 Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen

Country Status (6)

Country Link
EP (1) EP1206542B1 (de)
AT (1) ATE309354T1 (de)
AU (1) AU6675900A (de)
CA (1) CA2377730A1 (de)
DE (1) DE60023915T2 (de)
WO (1) WO2001014546A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976800A (en) * 1996-06-28 1999-11-02 The Regents Of The University Of California Enhancement of cancer cell death
CN1286530C (zh) * 1997-02-28 2006-11-29 贝林格尔·英格海姆药物公司 通过基因治疗炎性细胞的自我调节的细胞凋亡

Also Published As

Publication number Publication date
DE60023915T2 (de) 2006-08-10
WO2001014546A2 (en) 2001-03-01
EP1206542A2 (de) 2002-05-22
CA2377730A1 (en) 2001-03-01
WO2001014546A3 (en) 2001-11-29
DE60023915D1 (de) 2005-12-15
AU6675900A (en) 2001-03-19
EP1206542B1 (de) 2005-11-09

Similar Documents

Publication Publication Date Title
BG104599A (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
EP1140840A4 (de) -g(v)-carboxyaryl substituierte diphenyl harnstoffe als raf kinase inhibitoren
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
IL136738A0 (en) Inhibition of p38 kinase activity using substituted heterocyclic ureas
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
ATE380548T1 (de) Verwendung von p53 inhibitoren zur behandlung von nebenerscheinungen bei der krebstherapie
DE69936444D1 (de) Systemische verabreichung von serum-stabilen plasmid-lipid partikeln zur krebstherapie
NO326660B1 (no) Imidazolyl-cykliske acetal forbindelser, farmasøytiske sammensetninger inneholdende disse forbindelser og anvendelse av forbindelsene
DE69837393D1 (de) Stimulierung von hämatopoietischen zellen im vitro
NO961888D0 (no) Peptidylforbindelser og deres terapeutiske anvendelse som inhibitorer av metallproteinaser
AU2002343557A1 (en) Substituted aryl 1,4-pyrazine derivatives
MXPA01010393A (es) Tratamiento de neoplasmas con virus.
NO20000752L (no) Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser
ES2167401T3 (es) Uso de ascorbil-gamma-linolenato o un ascorbil-dihomo-gamma-linolenato para el tratamiento de asma, cancer, enfermedades cardiovasculares y anti-inflamatorias.
ZA954099B (en) Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders
BG103832A (en) Leptin as tumour cells proliferation inhibitor
ZA971891B (en) Use of aryl N-substituted carboxamides directly and as radio- and chemosensitizers for killing tumor and cancer cells and novel compounds for such use
NO20014537L (no) AKT-nukleinsyrer, -polypeptider og anvendelse av disse
DE60036105D1 (de) Herpes-simplex virus, das das gen von interleukin-12 exprimiert, und dessen verwendung zur behandlung von krebs
TW200503717A (en) Substituted 1,4-pyrazine derivatives
ATE309354T1 (de) Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen
MXPA04011018A (es) Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.
WO2001036680A3 (en) METHODS OF PREPARING cRNA
WO2002101076A3 (en) Methods for targeted expression of therapeutic nucleic acid
ATE310100T1 (de) Screeningverfahren für modulatoren von methyltransferase abhängiger chromosomenstabilität

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties